Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

The malignant pilomatricoma showed strong epithelial keratin expression, suggesting it may not calcify.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

The main cause of excessive hair growth in Turkish women is Polycystic ovary syndrome, but in about one fifth of cases, the reason for high male hormone levels is unknown.

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

A man developed a benign tumor at his COVID-19 vaccination site, which was successfully removed with surgery.

Finasteride increases CD8+ T cells in BPH tissues.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

Older men with high total testosterone might not show symptoms, while younger men with hyperandrogenism may experience hair loss or acne.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Recognizing and fully removing giant pilomatrixomas is crucial to prevent them from becoming cancerous.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

Mutations in the SHH pathway in certain skin cells can cause skin tumors and abnormal hair growth.

Certain drugs can cause male infertility, so fertility counseling and sperm preservation are advised.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Hirsutism in females is caused by high male hormones or sensitive hair follicles.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Hyperandrogenism causes significant physical and emotional challenges, needing better understanding and support.

Pilomatrixomas likely originate from the hair matrix due to changes in hair keratin expression.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.